$119 Million is the total value of Healthcare Value Capital, LLC's 33 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMAG | Exit | AMAG PHARMACEUTICALS INCcall | $0 | – | -20,000 | -100.0% | -0.25% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.27% | – |
| FURX | Exit | FURIEX PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.28% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -200,000 | -100.0% | -0.37% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -103,185 | -100.0% | -0.45% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -10,000 | -100.0% | -0.48% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -106,735 | -100.0% | -0.62% | – |
| PCYC | Exit | PHARMACYCLICS INCput | $0 | – | -10,000 | -100.0% | -0.66% | – |
| QLTI | Exit | QLT INCcall | $0 | – | -200,000 | -100.0% | -0.73% | – |
| ITMN | Exit | INTERMUNE INCcall | $0 | – | -50,000 | -100.0% | -1.10% | – |
| VXX | Exit | BARCLAYS BK PLCcall | $0 | – | -50,000 | -100.0% | -1.38% | – |
| HNT | Exit | HEALTH NET INCcall | $0 | – | -100,000 | -100.0% | -2.22% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -100,000 | -100.0% | -2.22% | – |
| QLTI | Exit | QLT INC | $0 | – | -626,639 | -100.0% | -2.28% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -75,000 | -100.0% | -2.59% | – |
| BAX | Exit | BAXTER INTL INCcall | $0 | – | -100,000 | -100.0% | -4.81% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INCput | $0 | – | -125,000 | -100.0% | -5.19% | – |
| MDY | Exit | SPDR S&P MIDCAP 400 ETF TRput | $0 | – | -50,000 | -100.0% | -8.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.